27.05.2010
- Europe's economic jitters will clean out the health-science industry, leaving global generic as well as innovative drugmakers among the survivors, the head of Swiss drugmaker Roche...
27.05.2010
- Top Pfizer research executive Martin Mackay has left the world's biggest drugmaker to head research at rival AstraZeneca as both companies brace for patent expirations on their top...
26.05.2010
- Israel's Teva Pharmaceutical Industries is developing a generic version of Roche's blockbuster antibody drug Rituxan, highlighting the race to produce so-called biosimilar...
18.05.2010
- IP Protection - In the pharmaceutical industry, the discovery of a new compound is often just the beginning of a series of inventions. During various steps of the development...
18.05.2010
- Déjà vu - It's a little bit like all those scenes in the movie "Groundhog Day," where Bill Murray wakes up over and over again to "I've Got You Babe" on his alarm radio, forced...
17.05.2010
- Astellas Pharma, Japan's No.2 drugmaker, seeks to buy at least 90% of shares in U.S. drugmaker OSI Pharmaceuticals with its tender offer, the company's chief executive said on...
12.05.2010
- Merck & Co plans to seek approval for five new medicines this year, including a closely watched hepatitis C treatment, but has halted development of an experimental anemia medicine...
05.05.2010
- Kathleen Jaeger, the chief lobbyist for the generic drugs industry during the debate over U.S. healthcare reform, is resigning as head of the Generic Pharmaceutical Association...
22.04.2010
- U.S. biotech company Codexis priced shares in its initial public offering at the bottom of the expected range on Wednesday in its second attempt to list its shares for public trade...
21.04.2010
- Intense competition amongst all end users is driving the European Manufacturing Execution System Market (MES). The end users from both process and discrete industries are going to...
